Iron treatment before heart surgery in people with low iron or anemia
Observes iron correction before heart surgery and its link to fewer transfusions.
Key facts
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Patient Blood Management in Patients Scheduled for Cardiac Surgery
- Status
- Recruiting
- People taking part
- 464 people, planned
- Started
- 24 Feb 2025
- Expected to end
- 28 Feb 2027
- Type of study
- Observational, 3 groups
- Treatments tested
- Iron
- Record updated
- 10 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are scheduled for planned heart surgery. Low iron levels are checked and treated with iron before surgery.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Scheduled for planned (elective) heart surgery
Main reasons for not taking part
- Pregnancy
- Being on dialysis
- Not wanting to take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- all adult patients scheduled for elective cardiac surgery
Who cannot take part
- pregnancy
- dyalisis
- patient's refusal
This trial is currently available in Italy.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The ICARUS 2 study has the general objective of collecting data in patients undergoing cardiac surgery; in our centre, in order to optimize and improve hemoglobin values, a team of haematologists, assisted by cardio anesthetists and cardiac surgeons, will evaluate the blood tests of patients scheduled for elective cardiac surgery in order to correct any states of hypoferritinemia (low iron in the blood) to promote recovery from blood losses related to cardiac surgery. This objective is strongly encouraged by the good use of blood programs currently in force at our foundation.
Read full original descriptionShow less
In particular, the research presented here intends to demonstrate a reduction in the number of intra- and post-operative transfusions.
The 3 groups in the trial
- Prospectic cohort
patients scheduled for cardiac surgery who fulfil the inclusion criteria
Treatment: Iron
- retrospective cohort ICARUS 1
patients scheduled for cardiac surgery (2021) with a known iron status, treated if indicated 1 or 2 days before surgery with iron supplementation.
- retrospective cohort
patients scheduled for cardiac surgery (2019-2020)with an unknown iron status and never treated with iron supplementation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Patient Blood Management in Cardiac Surgical Patients: the ICARUS-2 Study
- Plain-language title
- Iron treatment before heart surgery in people with low iron or anemiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 10 September 2026